Adial Pharmaceuticals

$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-6.80%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADIL and other stocks, options, and ETFs commission-free!

About ADIL

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA. The listed name for ADIL is Adial Pharmaceuticals, Inc Common Stock.

CEO

William B. Stilley

Employees

Headquarters

Charlottesville, Virginia

Founded

2010

Market Cap

27.90M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

543.45K

High Today

$2.10

Low Today

$1.92

Open Price

$2.07

Volume

328.44K

52 Week High

$4.00

52 Week Low

$1.00

Collections

ADIL Earnings

-$0.24

-$0.16

-$0.08

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 19, Pre-Market